Nuwellis

NUWE58

Penny Stock

$1.34arrow_drop_down1.11%-$0.01

Penny Stock

NUWE58

$1.34

arrow_drop_down1.11%-$0.01

Penny Stock

Performance History

Key Stats
Open	$1.35
Prev. Close	$1.35
EPS	-120.96
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.52M
PE Ratio	-

	LOW	HIGH
Day Range	1.32	1.43
52 Week Range	1.00	49.35

Ratios

Revenue	-





EPS	-120.96

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Nuwellis (NUWE)

Nuwellis, Inc., formerly CHF Solutions, Inc., is a medical device company that specializes in developing and commercializing innovative products for the treatment of fluid overload and related conditions. The company's flagship product, the Aquadex FlexFlow(R) System, is a clinically proven therapy for removing excess fluid from patients suffering from fluid overload. This cutting-edge system uses a unique ultrafiltration technology to safely and effectively remove fluid without the need for large volumes of intravenous diuretics. The Aquadex FlexFlow System offers several advantages over traditional diuretic therapy, including faster fluid removal, improved patient comfort, and reduced hospitalization costs.

In addition to its flagship product, Nuwellis is also developing a range of other innovative therapies for fluid management. These include the CAR-20 system, a catheter-based solution for acute decompensated heart failure, and the PURE-HF system, a portable ultrafiltration system for use in outpatient settings. These products have the potential to revolutionize the way fluid overload is managed, providing more efficient, cost-effective, and patient-friendly treatment options.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Nestor Jaramillo Jr.
Headquarters: Eden Prairie
Employees: 70
Exchange: NASDAQ

Keep an eye on Nuwellis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Nuwellis (NUWE)?

Nuwellis (NUWE) has a market capitalization of $2.52M. The average daily trading volume is 1.36, indicating the stock's liquidity and investor engagement.

help

What is Nuwellis's (NUWE) price per share?

The current price per share for Nuwellis (NUWE) is $1.34. The stock has seen a price change of -$0.02 recently, indicating a -1.11% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Nuwellis (NUWE)?

For Nuwellis (NUWE), the 52-week high is $49.35, which is 3.58K% from the current price. The 52-week low is $1, the current price is 34% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Nuwellis (NUWE) a growth stock?

Nuwellis (NUWE) has shown an average price growth of -6.8% over the past three years. It has received a score of 55 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nuwellis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Nuwellis (NUWE) stock price performance year to date (YTD)?

As of the latest data, Nuwellis (NUWE) has a year-to-date price change of -94.45%. Over the past month, the stock has experienced a price change of -9.46%. Over the last three months, the change has been -32.66%. Over the past six months, the figure is -85.09%.

help

Is Nuwellis (NUWE) a profitable company?

Nuwellis (NUWE) has a net income of -$20.21M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.22% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -105.74% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 3.76%, providing insight into the company's sales performance and growth. The gross profit is $4.98M. Operating income is noted at -$17.63M. Furthermore, the EBITDA is -$13.48M.